✦ LIBER ✦

PMH31 12 MONTH COST-UTILITY ANALYSIS OF ORAL ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY

✍ Scribed by M Knapp; F Windmeijer; JM Haro; S Kontodimas; J Brown; S Tzivelekis; D Novick; M Ratcliffe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH27 12-MONTH COST-EFFECTIVENESS ANALYS

✍ M Knapp; F Windmeijer; JM Haro; S Kontodimas; J Brown; S Tzivelekis; D Novick; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMH24 36-MONTH COST-UTILITY ANALYSIS OF

✍ F Windmeijer; J Brown; D Novick; J Hong; M Knapp; S Kontodimas; M Ratcliffe 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PMH35 THE COST OF RELAPSE IN PATIENTS WI

✍ G Zhu; J Brown; D Novick; D Suarez; JM Haro; F Windmeijer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

The cost of relapse in patients with sch

✍ Jihyung Hong; Frank Windmeijer; Diego Novick; Josep Maria Haro; Jacqueline Brown 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Use of concomitant medication with antip

✍ Diego Novick; Manuel Bousono; David Suarez; Jose M. Olivares; Angel L. Montejo; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

0428 EFFECTIVENESS OF ANTIPSYCHOTIC TREA

✍ D. Novick; D. Suarez; I. Gasquet; J.M. Haro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB